Simon Vyse
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in ⓘ
-
- Cancer therapeutics and mechanisms 3
- Protein Degradation and Inhibitors 2
- Oncology 9
- Colorectal Cancer Treatments and Studies 2
- Viral-associated cancers and disorders 2
- Cancer Cells and Metastasis 2
- Co-authors
- Paul H. Huang (13 shared papers)Aik Choon Tan (3 shared papers)Myles Lewis (4 shared papers)Timothy J. Vyse (4 shared papers)Patrick Gordon (3 shared papers)Adrian Shields (3 shared papers)Andrew Jenks (3 shared papers)Henning Walczak (2 shared papers)
- Journals
- Cell Reports (2 papers)IUCrJ (1 paper)Human Molecular Genetics (1 paper)Drug Discovery Today (1 paper)Seminars in Cancer Biology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Simon Vyse
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 489
- Pulmonary and Respiratory Medicine 525
- Cancer Research 219
- Molecular Biology 532
- Immunology 125
Countries citing papers authored by Simon Vyse
This map shows the geographic impact of Simon Vyse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Vyse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Vyse more than expected).
Fields of papers citing papers by Simon Vyse
This network shows the impact of papers produced by Simon Vyse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Vyse. The network helps show where Simon Vyse may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Vyse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer Hit paper breakdown → | 2019 | 397 |
| 2 | 2019 | 243 | |
| 3 | 2018 | 89 | |
| 4 | 2015 | 79 | |
| 5 | 2016 | 40 | |
| 6 | 2017 | 35 | |
| 7 | 2016 | 31 | |
| 8 | 2016 | 30 | |
| 9 | 2016 | 29 | |
| 10 | 2017 | 24 | |
| 11 | 2021 | 21 | |
| 12 | 2021 | 21 | |
| 13 | 2016 | 20 | |
| 14 | 2021 | 16 | |
| 15 | 2015 | 15 | |
| 16 | 2017 | 13 | |
| 17 | 2017 | 12 |
About Simon Vyse
Simon Vyse is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Pathology and Forensic Medicine, having authored 17 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer therapeutics and mechanisms (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Protein Degradation and Inhibitors (2 papers), Galectins and Cancer Biology (2 papers), Cell Adhesion Molecules Research (2 papers), Viral-associated cancers and disorders (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Oncology (489 citations), Pulmonary and Respiratory Medicine (525 citations), Cancer Research (219 citations), Molecular Biology (532 citations) and Immunology (125 citations). Simon Vyse has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul H. Huang, Aik Choon Tan, Myles Lewis, Timothy J. Vyse, Patrick Gordon, Adrian Shields, Andrew Jenks, Henning Walczak, Paul J. Lehner and Sebastian Boeltz. Their work appears in journals such as Cell Reports, IUCrJ, Human Molecular Genetics, Drug Discovery Today and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.